高级检索
当前位置: 首页 > 详情页

PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic Triple-negative Breast Cancer

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究参与人:
研究单位: [1]Biotheus Inc. [2]Fudan University [3]The first affiliated hospital of bengbu medical University,Bengbu,Anhui,China [4]The First Affiliated Hospital of Anhui Medical University,Hefei,Anhui,China [5]Cancer Hospital Chinese Academy of Medical Sciences,Beijing,Beijing,China [6]Fifth Medical Center of Chinese PLA General Hospital,Beijing,Beijing,China [7]Chongqing University Cancer Hospital,Chongqing,Chongqing,China [8]The First Affiliated Hospital of Chongqing Medical University,Chongqing,Chongqing,China [9]The Southwest Hospital of Army Medical University,Chongqing,Chongqing,China [10]Fujian Provincial Cancer Hospital,Fuzhou,Fujian,China [11]Lanzhou University First Hospital,Lanzhou,Gansu,China [12]The First People's Hospital of Foshan,Foshan,Guangdong,China [13]Affillated Cancer Hospital and Institute of Guangzhou Medical University,Guangzhou,Guangdong,China [14]Sun Yat-sen Memorial Hospital Affiliated to Sun Yat-sen University,Guangzhou,Guangdong,China [15]Sun Yat-sen University Cancer Center,Guangzhou,Guangdong,China [16]Yuebei People's Hospital,Shaoguan,Guangdong,China [17]Guangxi Medical University Cancer Hospital,Nanning,Guangxi,China [18]The First Affiliated Hospital of Guangxi Medical University,Nanning,Guangxi,China [19]Affiliated Hospital of Hebei University,Baoding,Hebei,China [20]The Fourth Hospital of Hebei Medical University,Shijiazhuang,Hebei,China [21]Harbin Medical University Cancer Hospital,Harbin,Heilongjiang,China [22]The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology,Anyang,Henan,China [23]The First Affiliated Hospital of Henan University of Science and Technology,Luoyang,Henan,China [24]Nanyang Central Hospital,Nanyang,Henan,China [25]The First Affiliated Hospital of Xinxiang Medical University,Xinxiang,Henan,China [26]Henan Cancer Hospital,Zhengzhou,Henan,China [27]The First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan,China [28]Hubei Cancer Hospital,Wuhan,Hubei,China [29]Union Hospital Tongji Medical College of Hust,Wuhan,Hubei,China [30]Zhongnan Hospital of Wuhan University,Wuhan,Hubei,China [31]The First People's Hospital of Changde City,Changde,Hunan,China [32]Hunan Cancer Hospital,Changsha,Hunan,China [33]Xiangyang Cancer Hospital,Xiangyang,Hunan,China [34]The Central Hospital of Yongzhou,Yongzhou,Hunan,China [35]Jiangsu Province Hospital,Nanjing,Jiangsu,China [36]The Affiliated Hospital of Nantong University,Nantong,Jiangsu,China [37]The Second Affiliated Hospital of Suzhou University,Suzhou,Jiangsu,China [38]Xuzhou Central Hospital,Xuzhou,Jiangsu,China [39]Northern Jiangsu People's Hospital,Yangzhou,Jiangsu,China [40]Jiangxi Cancer Hospital,Nanchang,Jiangxi,China [41]Jilin Cancer Hospital,Changchun,Jilin,China [42]The First Hospital of Jilin University,Changchun,Jilin,China [43]Affiliated Zhongshan Hospital of Dalian University,Dalian,Liaoning,China [44]The Second Hospital Of Dalian Medical University,Dalian,Liaoning,China [45]Liaoning Cancer Hospital,Shenyang,Liaoning,China [46]Shengjing Hospital of China Medical University,Shenyang,Liaoning,China [47]The First Hospital of China Medical University,Shenyang,Liaoning,China [48]The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shaanxi,China [49]The Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shaanxi,China [50]Shandong Cancer Hospital,Jinan,Shandong,China [51]Affiliated hospital of Jining Medical University,Jining,Shandong,China [52]Linyi Cancer Hospital,Linyi,Shandong,China [53]The Affiliated Hospital of Qingdao University,Qingdao,Shandong,China [54]Weifang People's Hospital,Weifang,Shandong,China [55]Fudan University Shanghai Cancer Center,Shanghai,Shanghai,China [56]Obstetrics and Gynecology Hospital of Fudan University,Shanghai,Shanghai,China [57]Ruijin hospital of Shanghai Jiao Tong university School of Medicine,Shanghai,Shanghai,China [58]Shanxi cancer hospital,Taiyuan,Shanxi,China [59]Runcheng City Center Hospital,Yuncheng,Shanxi,China [60]Sichuan Cancer Hospital,Chengdu,Sichuan,China [61]Sichuan Provincial People's Hospital,Chengdu,Sichuan,China [62]Mianyang Central Hospital,Mianyang,Sichuan,China [63]Nanchong Central Hospital of Sichuan Province,Nanchong,Sichuan,China [64]The First People's Hospital of Neijiang,Neijiang,Sichuan,China [65]The Second People's Hospital Of Neijiang,Neijiang,Sichuan,China [66]Suining Central Hospital,Suining,Sichuan,China [67]Tian Jin Medicial University Cancer Institute&Hospital,Tianjin,Tianjin,China [68]Yunnan Cancer Hospital (The Third Affiliated Hospital of Kunming Medical University),Kunming,Yunnan,China [69]The Second Affiliated Hospital Zhejiang University School Of Medicine,Hangzhou,Zhejiang,China [70]Zhejiang Cancer Hospital,Hangzhou,Zhejiang,China [71]Taizhou Hospital of Zhejiang Province,Taizhou,Zhejiang,China [72]The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang,China

研究目的:
This multicenter, randomized, double-blind study will evaluate the safety and efficacy of PM8002 in combination with Nab-Paclitaxel compared with placebo combined with Nab-Paclitaxel as first-line treatment in inoperable locally advanced/metastatic triple-negative breast cancer(TNBC)

资源点击量:53080 今日访问量:0 总访问量:4588 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号